Brickell Biotech, Inc. BBI
2.35 +2.35
Day range unavailable
52-week range unavailable
Analyst view
Consensus: buy
Buy
Price target (mean) 17.83 +658.7% upside
Now 2.35
- Target (low)
- 4.00
- Target (mean)
- 17.83
- Target (high)
- 45.00
Ratings (-1m) 4 4 buy · 0 hold · 0 sell
- Strong buy2
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- 1 month ago 4
- 2 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | -7.20 | 0.0% | 210.00K | +59.1% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | -2.70 | 0.0% | 1.54M | +1380.8% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 6.15M | +1422.3% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 7.12M | +15.8% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 16, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| May 13, 2022 | Lake Street | Downgrade | Buy | Hold |
| Mar 8, 2022 | William Blair | Initiated | — | Outperform |
| Jan 18, 2022 | HC Wainwright & Co. | Initiated | — | Buy |
| Aug 28, 2020 | Lake Street | Initiated | — | Buy |
| Aug 25, 2020 | Oppenheimer | Initiated | — | Outperform |